Importantly, the immunohistochemical analyses have indicated that the increased expression levels of SHH and GLI-1 frequently occur in prostatic adenocarcinoma tissue specimens relative to non-malignant prostate tissues (Figure 1). The gene discussed is GLI1; the disease is prostate adenocarcinoma.